November 3, 2015
Sanofi and BioNTech Announce Cancer Immunotherapy Collaboration and License Agreement
Sanofi and BioNTech A.G. have entered into a multiyear exclusive collaboration and license agreement.
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
November 2, 2015
Bayer’s flupyradifurone approved by EC
Bayer CropScience has reached an important milestone towards the market introduction of its innovative insecticide Sivanto prime in Europe.
November 2, 2015
Lilly expands its Indianapolis R&D headquartes
Eli Lilly and Company has revealed plans to expand its global research and development (R&D) headquarters in Indianapolis, Indiana.
October 30, 2015
NIH researchers link single gene variation to obesity
A single variation in the gene for brain-derived neurotropic factor (BDNF) may influence obesity in children and adults, according to a new study funded by the National Institutes of Health.
October 30, 2015
Bayer’s Eylea approved for Myopic CNV
Eylea is now also approved for the treatment of visual impairment due to myopic choroidal neovascularization (myopic CNV).
October 30, 2015
Lonsurf for colerectal cancer patients approved by FDA
United States Food and Drug Administration (FDA) has approved Lonsurf (trifluridine and tipiracil) tablets for the treatment of patients with metastatic colorectal cancer who have been previously…
October 30, 2015
Allergan, Pfizer in merger talks
Allergan plc has confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction.
October 29, 2015
Novartis Foundation and partners launch new hypertension program in Ghana
The Novartis Foundation and its partners have begun screening patients in the Community-based Hypertension Improvement Project (ComHIP), a two-year program designed to evaluate the impact of an innovative healthcare model on hypertension management and control in Ghana
October 29, 2015
FDA approved BMS’s Yervoy
U.S. Food and Drug Administration (FDA) has approved BMS’s Yervoy (ipilimumab) 10 mg/kg for the adjuvant treatment of patients with cutaneous melanoma with pathologic involvement of regional lymph nodes of more than 1 mm who have undergone complete resection including total lymphadenectomy.
October 28, 2015
Plandai in agreement with Bal Pharma for Phytofare
Plandaí Biotechnology, Inc., has executed an Exclusive Distribution Agreement with Bal Pharma Ltd., an India-based manufacturer and exporter of pharmaceutical finished formulation/bulk drugs and distributor of nutraceuticals ingredients.